| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999580 | Urologic Oncology: Seminars and Original Investigations | 2016 | 6 Pages |
Abstract
In summary, urine YKL-40 levels can be used to assist BTA in the diagnosis of bladder cancer as a marker for early invasiveness and thus help determine its treatment regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ozgur M.D., Tulay Ph.D., Can M.D., Fethi A. M.D.,